31 January 2024
Latham & Watkins Represents Akebia Therapeutics in Term Loan Financing
Advising firms
Deal team
6 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jennifer Kent Lead | Latham & Watkins LLP | Partner | finance | Washington, D.C. |
| Trevor Church | Latham & Watkins LLP | Associate | finance | Not stated |
| Jake Goodman | Latham & Watkins LLP | Associate | finance | Not stated |
| Jack Gillen | Latham & Watkins LLP | Associate | finance | Not stated |
| Wesley Holmes | Latham & Watkins LLP | Partner | corporate | Boston |
| Samuel Niles | Latham & Watkins LLP | Associate | corporate | New York |
3 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 55m (US$55 million)
- What the figure measures
- Facility amount
- Client
- Akebia Therapeutics, Inc.Borrower
- Counterparties
- BlackRock (Lenders)